Clinical Trial Update: Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating adoptive immunotherapy with Aldesleukin and Zoledronate in patients with stage IV kidney cancer and lung metastases has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Lung Cancer

Drugs mentioned

• Aldesleukin (interleukin-2)
• Zoledronate (zoledronic acid)

Snippet

Sponsor: Tokyo Women's Medical University | Conditions: Kidney Cancer, Metastatic Cancer | Phase 1, Phase 2 | Status: COMPLETED